此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Study on the Influence of Forest Therapy on Healing Experience in Botanical Gardens.

2022年1月26日 更新者:Chung-Hua Hsu、Taipei City Hospital
The forest healing system is an important topic of alternative therapy in recent years. To study the influence of Forest therapy, the establishment of a pilot experimental model system in which both environmental factors and type of activity are necessary. Therefore, a system based on the Taipei Botanical Garden was introduced by this study.

研究概览

详细说明

The forest healing system is an important topic of alternative therapy in recent years. Forest therapy began in 1989 when the psychology professor Kaplan put forward the "Attention Restoration Theory(ART)". Awareness has a positive benefit. To study the influence of Forest therapy, the establishment of a pilot experimental model system in which both environmental factors and type of activity are controlled can greatly reduce the errors caused by the site and the content of the activity. Therefore, a randomized controlled crossover experiment based on the Taipei Botanical Garden was introduced by this study.

研究类型

介入性

注册 (实际的)

42

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Taipei、台湾、10845
        • Taipei City Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

20年 至 35年 (成人)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • 20-35 years old youth (not limited to men and women)
  • Those who have the ability and physical strength to walk for more than 120 minutes
  • Subjects must voluntarily join the study

Exclusion Criteria:

  • People who smoke or chew betel nuts
  • People who have the habit of drinking (drinking more than five standard glasses in any situation)
  • Drug addiction (including narcotic drugs and non-narcotics) habitual
  • Those who have taken psychosomatic drugs in the past 30 days
  • Participating in another clinical trial at the same time, or in the follow-up period of an interventional trial
  • Those diagnosed with major injuries
  • Women who are currently pregnant or breastfeeding
  • Conditions where other subjects cannot cooperate (for example: unable to participate after random assignment, and not signing the subject's consent form)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:activities in the Botanical Garden or Urban
experiment group is activities in the Botanical Garden, and the control group is activities in urban
activities in the Taipei Botanical Garden or in Urban
其他:Cross-over design
The participants are randomized divided into in two groups following by the experiment which is designed by two consecutive times at one week intervals, and the experimental activities and the control activities are staggered.
activities in the Taipei Botanical Garden or in Urban

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
questionnaire: BPOMS (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline Brief Profile of Mood States at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BPOMS (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from Brief Profile of Mood States at second intervention after 7-day-washout period & cross-over
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
questionnaire: BAI (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline The Beck Anxiety Inventory at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BAI (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from The Beck Anxiety Inventory at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
questionnaire: BDI-II (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline The Beck Depression Inventory II at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BDI-II (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from The Beck Depression Inventory II at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
questionnaire: BSRS-V (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline Brief Symptom Rating Scale V at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BSRS-V (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from Brief Symptom Rating Scale V at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
physiological indicator: alpha-amylase activity in salivary (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline alpha-amylase activity in salivary by using commercial kits (Salimetrics®) at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
physiological indicator: alpha-amylase activity in salivary (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from alpha-amylase activity in salivary by using commercial kits (Salimetrics®) at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
physiological indicator: HRV (Heart Rate Variability) (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline HRV by using wrist monitors (ANSWatch®) to measure heart rate, heart rate variability (related to activities of the autonomic nervous system ANS), irregular heartbeats (IRRHB), and 5-minute continuous pulse wave at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
physiological indicator: HRV (Heart Rate Variability) (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from HRV by using wrist monitors (ANSWatch®) to measure heart rate, heart rate variability (related to activities of the autonomic nervous system ANS), irregular heartbeats (IRRHB), and 5-minute continuous pulse wave at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
physiological indicator: blood pressures (systolic and diastolic) (1st)
大体时间:baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline blood pressures by using wrist monitors (ANSWatch®) to measure blood pressures (systolic and diastolic) at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
physiological indicator: blood pressures (systolic and diastolic) (2nd)
大体时间:pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from blood pressures by using wrist monitors (ANSWatch®) to measure blood pressures (systolic and diastolic) at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Chung-Hua Hsu、Branch of Chinese Medicine, Taipei City Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年4月27日

初级完成 (实际的)

2021年4月27日

研究完成 (实际的)

2021年10月26日

研究注册日期

首次提交

2021年12月8日

首先提交符合 QC 标准的

2022年1月26日

首次发布 (实际的)

2022年2月8日

研究记录更新

最后更新发布 (实际的)

2022年2月8日

上次提交的符合 QC 标准的更新

2022年1月26日

最后验证

2022年1月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • TCHIRB-11002014

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅